Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gladiator Therapeutics is a private U.S. medical device company developing and commercializing non-powered far infrared therapy devices for wound healing, post-surgical recovery, pain relief, and related recovery applications. Its core technology, SemiCera®, is incorporated into wearable and blanket-style products designed to improve circulation, reduce inflammation, and support tissue repair without drugs or an external power source. The company markets devices for multiple body regions and promotes applications in chronic wounds, surgical recovery, and Parkinson's disease symptom support. Gladiator Therapeutics describes itself as an FDA-registered medical device research and manufacturing company and continues to advance additional use cases through case studies, animal research, and provider-focused commercialization. Overall, it is best characterized as a healthcare device company rather than a traditional drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gladiator Therapeutics.